title: Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans: Lost in translation.
authors.affiliation: Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Internal Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.
authors.forename: Cédric M
authors.initials: CM
authors.lastname: Hysek
authors.forename: Yasmin
authors.initials: Y
authors.lastname: Schmid
authors.forename: Anna
authors.initials: A
authors.lastname: Rickli
authors.forename: Matthias E
authors.initials: ME
authors.lastname: Liechti
mesh_terms: D018674:Adrenergic Antagonists / Q000494:pharmacology*; D001831:Body Temperature / Q000187:drug effects*; D002227:Carbazoles / Q000494:pharmacology*; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000494:pharmacology*; D011412:Propanolamines / Q000494:pharmacology*
chemical_list: D018674:Adrenergic Antagonists; D002227:Carbazoles; D011412:Propanolamines; D018817:N-Methyl-3,4-methylenedioxyamphetamine
references.citation: Drug Alcohol Depend. 2012 Feb 1;121(1-2):1-9
references.pmid: 21924843
references.citation: J Pharmacol Exp Ther. 2007 Jan;320(1):274-80
references.pmid: 17012607
references.citation: Nature. 2003 Nov 27;426(6965):403-4
references.pmid: 14647371
references.citation: Anesthesiology. 2004 Jul;101(1):263; author reply 264
references.pmid: 15220814
references.citation: Psychopharmacology (Berl). 2012 Dec;224(3):363-76
references.pmid: 22700038
references.citation: J Psychopharmacol. 2013 Jan;27(1):40-52
references.pmid: 23118021
references.citation: J Accid Emerg Med. 1998 Sep;15(5):322-6
references.pmid: 9785160
references.citation: J Clin Psychopharmacol. 2013 Oct;33(5):658-66
references.pmid: 23857311
references.citation: Health Technol Assess. 2009 Jan;13(6):iii-iv, ix-xii, 1-315
references.pmid: 19195429
references.citation: Br J Pharmacol. 2010 Jul;160(5):1029-44
references.pmid: 20590597
references.citation: Physiol Behav. 1995 Nov;58(5):877-82
references.pmid: 8577883
references.citation: Lancet. 1992 Aug 15;340(8816):384-7
references.pmid: 1353554
references.citation: J Psychopharmacol. 2011 Apr;25(4):439-52
references.pmid: 20643699
references.citation: Eur J Anaesthesiol. 2013 Jan;30(1):29-37
references.pmid: 23138574
references.citation: Ann Emerg Med. 1985 Nov;14(11):1112-3
references.pmid: 4051280
references.citation: Am J Med. 1993 Jun;94(6):608-10
references.pmid: 8506886
references.citation: Psychopharmacology (Berl). 2001 Mar 1;154(2):161-8
references.pmid: 11314678
references.citation: Emerg Med J. 2010 Aug;27(8):586-9
references.pmid: 20378736
references.citation: Swiss Med Wkly. 2005 Oct 29;135(43-44):652-7
references.pmid: 16380853
references.citation: Br J Pharmacol. 2012 Aug;166(8):2277-88
references.pmid: 22404145
references.citation: Addiction. 2011 Jul;106(7):1293-300
references.pmid: 21320226
references.citation: Crit Rev Toxicol. 2012 Nov;42(10):854-76
references.pmid: 23030234
references.citation: PLoS One. 2012;7(5):e36476
references.pmid: 22574166
references.citation: Psychopharmacology (Berl). 2012 Apr;220(4):751-62
references.pmid: 21993879
references.citation: Crit Care Med. 2005 Jun;33(6):1311-6
references.pmid: 15942349
references.citation: CJEM. 2010 Sep;12(5):435-42
references.pmid: 20880437
references.citation: J Forensic Sci. 2007 Jul;52(4):951-3
references.pmid: 17524054